Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Approval From China’S Nmpa For Venlafaxine Extended-Release Capsules

Nov 11 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS:

APPROVAL FROM CHINA’S NMPA FOR VENLAFAXINE EXTENDED-RELEASE CAPSULES

VENLAFAXINE ER CAPSULES TO BE PRODUCED AT AHMEDABAD FACILITY

Further company coverage: ZYDU.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news